Milestone Posts Wider-Than-Expected Q3 Revenue, Narrows Loss to 18 Cents a Share
MIST is trading near its 52-week low of $0.631 (11% above the low) on light trading volume (0.2× avg).
Summary
Milestone lost 18 cents a share on an adjusted basis in Q3, better than the 22-cent loss seven analysts expected, and revenue came in at $2.96 million against a $1.14 million consensus. The quarter's net loss was $25.8 million. The revenue beat is the first real read on CARDAMYST's launch curve, and it lands alongside the cost cuts and CFO/CMO exits disclosed in today's 8-K and 10-Q. Still, the stock is down 24.3% this quarter and 67.6% this year, and it closed at $0.66 — below the $1.00 Nasdaq minimum, with a notice already received on October 23. The $7.00 median price target implies the Street is underwriting a launch that has not yet shown up in the share price.
At the time of this announcement, MIST was trading at $0.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $81.6M. The 52-week trading range was $0.63 to $3.06. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.